Home LiteratureArticle Details
PMID: 1867521 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins.

Annals of surgery ·Vol. 214 ·No. 2 ·1991-08-00 ·Pages 141-8

Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH

Abstract

Although the cytokines tumor necrosis factor (TNF), interleukin-1 (IL-1), and interleukin-6 (IL-6) are important mediators of hemodynamic, metabolic, and immunologic alterations in the host during sepsis, it is not known whether there is any association between the release of these cytokines and prostanoids during sepsis. Sepsis induced by cecal ligation and puncture in rats led to a persistent elevation (p less than 0.05) of plasma TNF until 10 hours, steadily increasing (p less than 0.05) IL-1 plasma levels, and enhanced (p less than 0.05) IL-6 plasma levels at all time points compared to the sham group. Prostaglandin E2 plasma levels were elevated (p less than 0.05) at 5 hours (153 +/- 29 pg/mL; control: 47 +/- 11 pg/mL) and 10 hours (96 +/- 16 pg/mL; control: 21 +/- 5 pg/mL). Prostaglandin E2 production by splenic macrophages (sM phi) from septic animals was increased (p less than 0.05) at 5 hours (9.1 +/- 2.2 ng/mL) and 10 hours (5.6 +/- 1.5 ng/mL) compared to controls (3.3 +/- 0.3 ng/mL at 5 hours; 1.3 +/- 1.3 ng/mL at 10 hours). Incubation of sM phi from septic animals with ibuprofen enhanced (p less than 0.05) IL-1 and TNF synthesis, while IL-6 production was reduced (p less than 0.05). These results indicate that the alterations in prostanoid release and elevated plasma prostanoids may regulate the release and consequently the circulating levels of cytokines during sepsis.

MeSH Terms
Animals Bacterial Infections/metabolism Cytokines/metabolism Dinoprostone/metabolism Endotoxins/blood Ibuprofen/pharmacology In Vitro Techniques Interleukin-1/metabolism Interleukin-6/metabolism Macrophages/drug effects,metabolism Male Rats Rats, Inbred Strains Spleen/metabolism Tumor Necrosis Factor-alpha/metabolism
Chemicals
Cytokines Endotoxins Interleukin-1 Interleukin-6 Tumor Necrosis Factor-alpha Dinoprostone Ibuprofen
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ertel W
Department of Surgery, Michigan State University, East Lansing 48824-1315.
Morrison M H
Wang P
Ba Z F
Ayala A
Chaudry I H
References (41)
41 references, click to expand
  1. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
    J Clin Invest. 1988 Jun;81(6):1925-37 PMID: 3384955
  2. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1433-50 PMID: 3486936
  3. WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.
    Immunol Invest. 1990 Feb;19(1):69-79 PMID: 2110931
  4. Human tumour necrosis factor-alpha (TNF-alpha) directly stimulates arachidonic acid release in human neutrophils.
    Immunology. 1990 May;70(1):82-7 PMID: 2162326
  5. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  6. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
    J Immunol Methods. 1986 Dec 4;95(1):99-105 PMID: 3782828
  7. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  8. Biology of interleukin 1.
    FASEB J. 1988 Feb;2(2):108-15 PMID: 3277884
  9. Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.
    JAMA. 1989 Jul 14;262(2):249-51 PMID: 2739019
  10. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.
    Am J Physiol. 1989 Mar;256(3 Pt 2):R659-65 PMID: 2784290
  11. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells.
    J Immunol. 1989 Jan 1;142(1):144-7 PMID: 2783321
  12. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
    J Exp Med. 1989 Jan 1;169(1):333-8 PMID: 2783334
  13. Biological activity of recombinant murine interleukin-6 in interleukin-1 T cell assays.
    J Immunol Methods. 1989 Jun 21;120(2):173-8 PMID: 2786911
  14. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.
    Crit Care Med. 1989 Oct;17(10):975-8 PMID: 2791581
  15. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.
    Clin Immunol Immunopathol. 1989 Dec;53(3):488-98 PMID: 2805453
  16. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
    J Exp Med. 1989 Nov 1;170(5):1627-33 PMID: 2809510
  17. Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.
    J Leukoc Biol. 1989 May;45(5):416-21 PMID: 2651547
  18. Tumour necrosis factor and bacterial sepsis.
    Br J Surg. 1989 Jul;76(7):670-1 PMID: 2670051
  19. Cachectin/tumour necrosis factor.
    Lancet. 1989 May 20;1(8647):1122-6 PMID: 2566060
  20. Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.
    J Exp Med. 1988 Jun 1;167(6):1987-92 PMID: 3290384
  21. Prostaglandins as endogenous mediators of interleukin 1 production.
    J Immunol. 1986 Jan;136(1):186-92 PMID: 3079606
  22. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Circ Shock. 1990 Mar;30(3):279-92 PMID: 2178801
  23. Stimulation of human chondrocyte prostaglandin E2 production by recombinant human interleukin-1 and tumour necrosis factor.
    Biochim Biophys Acta. 1990 Mar 9;1051(3):310-8 PMID: 2310781
  24. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.
    Am Rev Respir Dis. 1990 Jan;141(1):94-7 PMID: 2297191
  25. Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.
    Surg Gynecol Obstet. 1990 Jan;170(1):32-8 PMID: 2294627
  26. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.
    J Exp Med. 1983 Sep 1;158(3):836-56 PMID: 6193236
  27. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2474-7 PMID: 6264478
  28. Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.
    J Immunol. 1983 Feb;130(2):890-5 PMID: 6401308
  29. Regulation of the immune response by prostaglandins.
    Clin Immunol Immunopathol. 1980 Jan;15(1):106-22 PMID: 6987016
  30. Effect of sepsis on tissue adenine nucleotide levels.
    Surgery. 1979 Feb;85(2):205-11 PMID: 419461
  31. Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock.
    Ann Surg. 1991 Mar;213(3):265-71 PMID: 1998408
  32. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin.
    Cytokine. 1990 May;2(3):170-4 PMID: 2104220
  33. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.
    J Biol Chem. 1988 Apr 15;263(11):5380-4 PMID: 3162731
  34. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.
    Eur J Immunol. 1988 Aug;18(8):1259-64 PMID: 3138137
  35. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  36. Detection of circulating tumor necrosis factor after endotoxin administration.
    N Engl J Med. 1988 Jun 9;318(23):1481-6 PMID: 2835680
  37. Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells.
    FEBS Lett. 1988 Oct 24;239(1):50-4 PMID: 2846348
  38. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  39. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
    Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679-83 PMID: 2948184
  40. Cytokine appearance in human endotoxemia and primate bacteremia.
    Surg Gynecol Obstet. 1988 Feb;166(2):147-53 PMID: 3122336
  41. Release of eicosanoids from white blood cells, platelets, smooth muscle cells, and endothelial cells in response to endotoxin and A23187.
    Circ Shock. 1986;20(1):25-34 PMID: 3094976
Article Info
Journal
Annals of surgery
Abbr.
Ann Surg
ISSN
0003-4932
Published
1991-08-00
Pages
141-8
Language
English
Region
United States
NLM ID
0372354
PMCID
PMC1358513
Subset
IM
Grants
NIGMS NIH HHS · GM 39519 · United States
NIGMS NIH HHS · R01 GM 37127 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com